Abstract Background Chronic Hepatitis B Virus (HBV) infection is characterised by the
persistence of hepatitis B surface antigen (HBsAg). Expanding HBV diagnosis and treatment …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Despite the heavy disease burden posed by hepatitis B, around 90% of people living with
hepatitis B are not diagnosed globally. Many of the affected populations still have limited or …

Background. Crowdsourcing, the process of shifting individual tasks to a large group, may
enhance human immunodeficiency virus (HIV) testing interventions. We conducted a …

Abstract Background HIV, HBV and HCV pose a major public health problem throughout the
world. Detection of infection markers for these agents is a major challenge for testing …

Background Rapid point-of-care tests provide plausible diagnostic strategy for hepatitis B
surface antigen (HBsAg) in low resource areas. However, their utility depends upon their …

OBJECTIVES: Three-hundred fifty million people worldwide are chronically infected with
Hepatitis B, with four million acute infections annually. With infection concentrated in hard-to …

Introduction Chronic infection with hepatitis B virus (HBV) is a leading cause of morbidity
and death, especially in sub-Saharan Africa (SSA), where approximately 60 million adults …

Abstract Hepatitis B Virus (HBV) infection is one of the leading causes of death worldwide.
The most important marker for HBV infection is Hepatitis B Surface Antigen (HBSAg). HBSAg …

Background: Though measures are being put in place for the management of Hepatitis B
virus (HBV) infection in Nigeria, children remain the most vulnerable to develop chronic …